Interaction of amines and aminergic blocking agents with blood glucose regulation. II.  Alpha-adrenergic blockade.
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism; D000315:Adrenalectomy; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000588:Amines / Q000494:pharmacology*; D000818:Animals; D001786:Blood Glucose / Q000032:analysis*; D002247:Carbon Isotopes; D003921:Diabetes Mellitus, Experimental / Q000097:blood; D004347:Drug Interactions; D005260:Female; D006003:Glycogen / Q000032:analysis; D006706:Homeostasis / Q000187:drug effects; D007328:Insulin / Q000097:blood; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008112:Liver Glycogen / Q000032:analysis; D051379:Mice; D009132:Muscles / Q000032:analysis / Q000378:metabolism; D009638:Norepinephrine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology*
D000317:Adrenergic alpha-Antagonists; D000588:Amines; D001786:Blood Glucose; D002247:Carbon Isotopes; D007328:Insulin; D008112:Liver Glycogen; D013565:Sympatholytics; D006003:Glycogen; D011433:Propranolol; D009638:Norepinephrine; D010646:Phentolamine